activeFounded 2020
National Resilience
Funding Summary
Total Funding
$2B+
Latest Valuation
$4.6B (2022)
About
A next-generation biomanufacturing CDMO building capacity for advanced therapies including gene therapy, cell therapy, and mRNA. Acquired multiple manufacturing facilities to create a vertically integrated production network.
Products
biomanufacturing-cdmogene-therapy-manufacturingmrna-manufacturing
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →